Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith L Thijs

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Investigative Dermatology|February 21, 2021
Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic DermatitisDaphne S Bakker, Maria M van der Wal, Lukas E M Heeb, et al.
The Journal of Investigative Dermatology|August 1, 2021
ZFP36 Family Members Regulate the Proinflammatory Features of Psoriatic Dermal FibroblastsChiara Angiolilli, Emmerik F A Leijten, Cornelis P J Bekker, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2017
Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysisJudith L Thijs, Ian Strickland, Carla A F M Bruijnzeel-Koomen, et al.
Journal of the American Academy of Dermatology|September 18, 2020
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registryLieneke F M Ariëns, Jorien van der Schaft, Lotte S Spekhorst, et al.
Allergy|October 9, 2019
Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registryLieneke F M Ariëns, Jorien van der Schaft, Daphne S Bakker, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Investigative Dermatology|February 21, 2021
Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic DermatitisDaphne S Bakker, Maria M van der Wal, Lukas E M Heeb, et al.
The Journal of Investigative Dermatology|August 1, 2021
ZFP36 Family Members Regulate the Proinflammatory Features of Psoriatic Dermal FibroblastsChiara Angiolilli, Emmerik F A Leijten, Cornelis P J Bekker, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2017
Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysisJudith L Thijs, Ian Strickland, Carla A F M Bruijnzeel-Koomen, et al.
Journal of the American Academy of Dermatology|September 18, 2020
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registryLieneke F M Ariëns, Jorien van der Schaft, Lotte S Spekhorst, et al.
Allergy|October 9, 2019
Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registryLieneke F M Ariëns, Jorien van der Schaft, Daphne S Bakker, et al.
Pageof 2